Meihua International Medical Technologies Co., Ltd. Financials

MHUA

Source SEC Filings (10-K/10-Q) Updated Jun 30, 2025 Currency USD FYE December

This page shows Meihua International Medical Technologies Co., Ltd. (MHUA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 63/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Meihua International Medical Technologies Co., Ltd. has an operating margin of 14.8%, meaning the company retains $15 of operating profit per $100 of revenue. This results in a moderate score of 55/100, indicating healthy but not exceptional operating efficiency. This is down from 15.1% the prior year.

Growth

Meihua International Medical Technologies Co., Ltd.'s revenue declined 0.2% year-over-year, from $97.1M to $96.9M. This contraction results in a growth score of 33/100.

Leverage

Meihua International Medical Technologies Co., Ltd. carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 5.26, Meihua International Medical Technologies Co., Ltd. holds $5.26 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Meihua International Medical Technologies Co., Ltd. has a free cash flow margin of 15.0%, earning a moderate score of 62/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Meihua International Medical Technologies Co., Ltd. generates a 6.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 26/100. This is down from 7.9% the prior year.

Altman Z-Score Safe

11.68

Meihua International Medical Technologies Co., Ltd. scores 11.68, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($425.4M) relative to total liabilities ($27.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

4/9

Meihua International Medical Technologies Co., Ltd. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.35x

For every $1 of reported earnings, Meihua International Medical Technologies Co., Ltd. generates $1.35 in operating cash flow ($14.6M OCF vs $10.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

57.8x

Meihua International Medical Technologies Co., Ltd. earns $57.8 in operating income for every $1 of interest expense ($14.3M vs $248K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$96.9M

YoY-0.2%

5Y CAGR+4.0%

Meihua International Medical Technologies Co., Ltd. generated $96.9M in revenue in fiscal year 2024. This represents a decrease of 0.2% from the prior year.

EBITDA

$14.9M

YoY-1.7%

5Y CAGR-5.6%

Meihua International Medical Technologies Co., Ltd.'s EBITDA was $14.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.7% from the prior year.

Net Income

$10.8M

YoY-6.7%

5Y CAGR-6.8%

Meihua International Medical Technologies Co., Ltd. reported $10.8M in net income in fiscal year 2024. This represents a decrease of 6.7% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

$14.5M

YoY+1226.9%

5Y CAGR+9.9%

Meihua International Medical Technologies Co., Ltd. generated $14.5M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 1226.9% from the prior year.

Cash & Debt

$17.3M

YoY+2.1%

5Y CAGR+1.5%

Meihua International Medical Technologies Co., Ltd. held $17.3M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

32M

YoY+33.3%

Meihua International Medical Technologies Co., Ltd. had 32M shares outstanding in fiscal year 2024. This represents an increase of 33.3% from the prior year.

Margins & Returns

Gross Margin

34.4%

YoY+0.2pp

5Y CAGR-6.1pp

Meihua International Medical Technologies Co., Ltd.'s gross margin was 34.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin

14.8%

YoY-0.3pp

5Y CAGR-9.6pp

Meihua International Medical Technologies Co., Ltd.'s operating margin was 14.8% in fiscal year 2024, reflecting core business profitability. This is down 0.3 percentage points from the prior year.

Net Margin

11.2%

YoY-0.8pp

5Y CAGR-8.2pp

Meihua International Medical Technologies Co., Ltd.'s net profit margin was 11.2% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.8 percentage points from the prior year.

Return on Equity

6.8%

YoY-1.1pp

5Y CAGR-19.1pp

Meihua International Medical Technologies Co., Ltd.'s ROE was 6.8% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$3.5M

YoY+25.5%

5Y CAGR+1.5%

Meihua International Medical Technologies Co., Ltd. invested $3.5M in research and development in fiscal year 2024. This represents an increase of 25.5% from the prior year.

Share Buybacks

$200K

Meihua International Medical Technologies Co., Ltd. spent $200K on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$134K

YoY-88.7%

5Y CAGR-12.9%

Meihua International Medical Technologies Co., Ltd. invested $134K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 88.7% from the prior year.

MHUA Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$96.9M-0.2%	$97.1M-6.0%	$103.3M-0.7%	$104.0M+16.8%	$89.1M+11.8%	$79.6M
Cost of Revenue	$63.6M-0.5%	$63.9M-2.1%	$65.2M+1.6%	$64.2M+23.8%	$51.9M+9.5%	$47.4M
Gross Profit	$33.3M+0.3%	$33.2M-12.9%	$38.1M-4.3%	$39.8M+7.1%	$37.2M+15.4%	$32.2M
R&D Expenses	$3.5M+25.5%	$2.8M-7.1%	$3.0M+8.7%	$2.7M+9.3%	$2.5M-22.5%	$3.2M
SG&A Expenses	$7.8M+19.0%	$6.5M-47.5%	$12.5M+185.9%	$4.4M-4.7%	$4.6M+8.9%	$4.2M
Operating Income	$14.3M-2.5%	$14.7M+35.9%	$10.8M-58.9%	$26.3M+11.9%	$23.5M+21.0%	$19.4M
Interest Expense	$248K-1.3%	$251K+31.2%	$191K+5.8%	$181K+31.8%	$137K+40.3%	$98K
Income Tax	$2.8M-19.3%	$3.5M-26.6%	$4.7M-10.7%	$5.3M+12.6%	$4.7M+22.8%	$3.8M
Net Income	$10.8M-6.7%	$11.6M+86.2%	$6.2M-70.2%	$20.9M+10.0%	$19.0M+23.4%	$15.4M
EPS (Diluted)	N/A	$0.49+81.5%	$0.27-74.3%	$1.05+10.5%	$0.95	N/A

Metric	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q4'21	Q4'20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MHUA Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$186.2M+8.3%	$171.9M+5.1%	$163.6M+19.5%	$136.9M+29.1%	$106.0M	N/A
Current Assets	$143.4M+8.5%	$132.2M-2.3%	$135.3M+39.1%	$97.3M+44.0%	$67.6M	N/A
Cash & Equivalents	$17.3M+2.1%	$16.9M-36.7%	$26.7M+228.1%	$8.1M+13.4%	$7.2M-55.2%	$16.0M
Inventory	$1.4M-12.8%	$1.6M+44.1%	$1.1M-10.3%	$1.3M-5.6%	$1.3M	N/A
Accounts Receivable	$78.7M+0.1%	$78.6M+14.0%	$68.9M+2.7%	$67.1M+46.8%	$45.7M	N/A
Goodwill	$7.9M	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$27.3M+8.7%	$25.1M+0.7%	$24.9M-14.4%	$29.1M+36.5%	$21.3M	N/A
Current Liabilities	$27.3M+8.7%	$25.1M+3.7%	$24.2M-16.9%	$29.1M+36.5%	$21.3M	N/A
Long-Term Debt	N/A	N/A	$725K	N/A	N/A	N/A
Total Equity	$159.0M+8.6%	$146.3M+5.9%	$138.1M+28.2%	$107.8M+27.2%	$84.7M+42.0%	$59.7M
Retained Earnings	$105.2M+11.2%	$94.6M+13.6%	$83.3M+7.4%	$77.6M+37.0%	$56.6M	N/A

Metric	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q4'21	Q4'20
Total Assets	$190.6M+2.3%	$186.2M+3.9%	$179.2M+4.2%	$171.9M+5.7%	$162.6M-0.6%	$163.6M+19.5%	$136.9M+29.1%	$106.0M
Current Assets	$146.3M+2.0%	$143.4M+1.5%	$141.3M+6.9%	$132.2M0.0%	$132.3M-2.3%	$135.3M+39.1%	$97.3M+44.0%	$67.6M
Cash & Equivalents	$16.9M-2.2%	$17.3M-6.5%	$18.5M+9.2%	$16.9M-5.2%	$17.9M-33.2%	$26.7M+228.1%	$8.1M+13.4%	$7.2M
Inventory	$1.1M-21.9%	$1.4M+29.1%	$1.1M-32.5%	$1.6M-1.8%	$1.6M+46.8%	$1.1M-10.3%	$1.3M-5.6%	$1.3M
Accounts Receivable	$86.6M+10.1%	$78.7M-4.7%	$82.6M+5.1%	$78.6M-0.6%	$79.1M+14.7%	$68.9M+2.7%	$67.1M+46.8%	$45.7M
Goodwill	N/A	$7.9M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$25.6M-6.0%	$27.3M-7.9%	$29.6M+18.0%	$25.1M+8.0%	$23.2M-6.7%	$24.9M-14.4%	$29.1M+36.5%	$21.3M
Current Liabilities	$25.6M-6.0%	$27.3M-7.9%	$29.6M+18.0%	$25.1M+8.0%	$23.2M-3.9%	$24.2M-16.9%	$29.1M+36.5%	$21.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$725K	N/A	N/A
Total Equity	$164.9M+3.8%	$159.0M+6.3%	$149.6M+2.2%	$146.3M+5.4%	$138.9M+0.6%	$138.1M+28.2%	$107.8M+27.2%	$84.7M
Retained Earnings	$108.3M+2.9%	$105.2M+6.0%	$99.3M+4.9%	$94.6M+4.7%	$90.4M+8.5%	$83.3M+7.4%	$77.6M+37.0%	$56.6M

MHUA Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$14.6M+543.2%	$2.3M+124.8%	-$9.2M-16662.8%	-$55K-101.0%	$5.3M-42.8%	$9.3M
Capital Expenditures	$134K-88.7%	$1.2M-56.2%	$2.7M+217.4%	$850K-77.7%	$3.8M+1327.7%	$267K
Free Cash Flow	$14.5M+1226.9%	$1.1M+109.2%	-$11.9M-1210.8%	-$905K-159.6%	$1.5M-83.2%	$9.0M
Investing Cash Flow	-$20.4M-63.9%	-$12.5M-44.5%	-$8.6M-933.8%	-$834K+94.8%	-$16.1M-80.8%	-$8.9M
Financing Cash Flow	$6.2M+780.0%	$706K-98.1%	$37.2M+1902.2%	$1.9M+9.0%	$1.7M+84.8%	$924K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$200K	N/A	N/A	N/A	N/A	N/A

Metric	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q4'21	Q4'20
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MHUA Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	34.4%+0.2pp	34.2%-2.7pp	36.9%-1.4pp	38.3%-3.5pp	41.7%+1.3pp	40.5%
Operating Margin	14.8%-0.3pp	15.1%+4.7pp	10.4%-14.8pp	25.2%-1.1pp	26.4%+2.0pp	24.3%
Net Margin	11.2%-0.8pp	12.0%+5.9pp	6.0%-14.1pp	20.1%-1.2pp	21.4%+2.0pp	19.4%
Return on Equity	6.8%-1.1pp	7.9%+3.4pp	4.5%-14.9pp	19.4%-3.0pp	22.5%-3.4pp	25.9%
Return on Assets	5.8%-0.9pp	6.8%+2.9pp	3.8%-11.5pp	15.3%-2.6pp	18.0%	N/A
Current Ratio	5.26-0.0	5.27-0.3	5.60+2.3	3.34+0.2	3.17	N/A
Debt-to-Equity	0.170.0	0.17+0.2	0.01-0.3	0.27+0.0	0.25	N/A
FCF Margin	15.0%+13.8pp	1.1%+12.6pp	-11.5%-10.6pp	-0.9%-2.6pp	1.7%-9.7pp	11.4%

Metric	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q4'21	Q4'20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	5.71+0.4	5.26+0.5	4.78-0.5	5.27-0.4	5.70+0.1	5.60+2.3	3.34+0.2	3.17
Debt-to-Equity	0.16-0.0	0.17-0.0	0.20+0.0	0.170.0	0.17+0.2	0.01-0.3	0.27+0.0	0.25
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

$26.2M

$23.3M

$33.5M

$6.7M

$20.6M

Frequently Asked Questions

What is Meihua International Medical Technologies Co., Ltd.'s annual revenue?

Meihua International Medical Technologies Co., Ltd. (MHUA) reported $96.9M in total revenue for fiscal year 2024. This represents a -0.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Meihua International Medical Technologies Co., Ltd.'s revenue growing?

Meihua International Medical Technologies Co., Ltd. (MHUA) revenue declined by 0.2% year-over-year, from $97.1M to $96.9M in fiscal year 2024.

Is Meihua International Medical Technologies Co., Ltd. profitable?

Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) reported a net income of $10.8M in fiscal year 2024, with a net profit margin of 11.2%.

What is Meihua International Medical Technologies Co., Ltd.'s EBITDA?

Meihua International Medical Technologies Co., Ltd. (MHUA) had EBITDA of $14.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Meihua International Medical Technologies Co., Ltd.'s gross margin?

Meihua International Medical Technologies Co., Ltd. (MHUA) had a gross margin of 34.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Meihua International Medical Technologies Co., Ltd.'s operating margin?

Meihua International Medical Technologies Co., Ltd. (MHUA) had an operating margin of 14.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Meihua International Medical Technologies Co., Ltd.'s net profit margin?

Meihua International Medical Technologies Co., Ltd. (MHUA) had a net profit margin of 11.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Meihua International Medical Technologies Co., Ltd.'s return on equity (ROE)?

Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity of 6.8% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Meihua International Medical Technologies Co., Ltd.'s free cash flow?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.5M in free cash flow during fiscal year 2024. This represents a 1226.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Meihua International Medical Technologies Co., Ltd.'s operating cash flow?

Meihua International Medical Technologies Co., Ltd. (MHUA) generated $14.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Meihua International Medical Technologies Co., Ltd.'s total assets?

Meihua International Medical Technologies Co., Ltd. (MHUA) had $186.2M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Meihua International Medical Technologies Co., Ltd.'s capital expenditures?

Meihua International Medical Technologies Co., Ltd. (MHUA) invested $134K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Meihua International Medical Technologies Co., Ltd. spend on research and development?

Meihua International Medical Technologies Co., Ltd. (MHUA) invested $3.5M in research and development during fiscal year 2024.

Does Meihua International Medical Technologies Co., Ltd. buy back shares?

Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) spent $200K on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Meihua International Medical Technologies Co., Ltd. have outstanding?

Meihua International Medical Technologies Co., Ltd. (MHUA) had 32M shares outstanding as of fiscal year 2024.

What is Meihua International Medical Technologies Co., Ltd.'s current ratio?

Meihua International Medical Technologies Co., Ltd. (MHUA) had a current ratio of 5.26 as of fiscal year 2024, which is generally considered healthy.

What is Meihua International Medical Technologies Co., Ltd.'s debt-to-equity ratio?

Meihua International Medical Technologies Co., Ltd. (MHUA) had a debt-to-equity ratio of 0.17 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Meihua International Medical Technologies Co., Ltd.'s return on assets (ROA)?

Meihua International Medical Technologies Co., Ltd. (MHUA) had a return on assets of 5.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Meihua International Medical Technologies Co., Ltd.'s Altman Z-Score?

Meihua International Medical Technologies Co., Ltd. (MHUA) has an Altman Z-Score of 11.68, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Meihua International Medical Technologies Co., Ltd.'s Piotroski F-Score?

Meihua International Medical Technologies Co., Ltd. (MHUA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Meihua International Medical Technologies Co., Ltd.'s earnings high quality?

Meihua International Medical Technologies Co., Ltd. (MHUA) has an earnings quality ratio of 1.35x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Meihua International Medical Technologies Co., Ltd. cover its interest payments?

Meihua International Medical Technologies Co., Ltd. (MHUA) has an interest coverage ratio of 57.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Meihua International Medical Technologies Co., Ltd.?

Meihua International Medical Technologies Co., Ltd. (MHUA) scores 63 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.